ANDE The Andersons, Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ANDE Stock | Fundamental Analysis & Investment Insights
NASDAQ
Consumer Defensive
Food Distribution
Current Price
Live
$70.74
Analyst Target
$73.33
+3.7%
Upside
52W High
$71.54
52W Low
$31.03
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
The Andersons, Inc. (ANDE) exhibits mixed signals across the Advanced Deterministic Scorecard: a Piotroski F-Score of 4/9 indicates weak financial health, while the absence of an Altman Z-Score raises concern about default risk. The stock trades near its intrinsic value of $82.31 but at a premium to the Graham Number of $48.28, suggesting high growth expectations are priced in. Despite strong earnings growth (51.4% YoY) and a recent surge in EPS (142.9% Q/Q), revenue has declined sharply (-18.8% YoY), signaling underlying business headwinds. Insider selling activity and a bearish technical trend further temper optimism.
Key Strengths
Strong earnings growth (51.4% YoY) and recent Q/Q EPS surge (+142.9%) indicate operational recovery or one-time gains
Forward P/E of 12.59 suggests market expects improved profitability despite current high trailing P/E
Analyst consensus is strong_buy with a target price of $73.33, implying upside potential
Graham Number ($48.28) and intrinsic value ($82.31) provide a clear value framework, with the latter suggesting upside if growth is sustainable
Historical earnings surprise average of 20.14% over last 4 quarters reflects consistent beat potential
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health, signaling potential issues in profitability, leverage, or cash flow
Revenue declined 18.8% YoY, which is concerning for a consumer defensive stock and contradicts earnings growth
Insider selling activity (2 transactions, $0.18M) with no buys suggests internal skepticism
Technical trend is bearish (10/100), and price is near 52-week high ($71.54), limiting near-term upside
Lack of Altman Z-Score and missing financials (cash, debt, FCF) prevent full health assessment; high debt/equity (0.75) and low quick ratio (0.45) are red flags
AI Fair Value Estimate
Based on comprehensive analysis
$82.31
+16.4% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ANDE against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ANDE from our newsroom.
Newest → oldest
No matching news yet.